Filtros de búsqueda

Lista de obras de M Ong

A Systematic Review of the Incidence and Risk Factors for Taxane Acute Pain Syndrome in Patients Receiving Taxane-Based Chemotherapy for Prostate Cancer

artículo científico publicado en 2016

A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer

artículo científico publicado en 2020

AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer - results of two parallel first-in-human phase I studies

artículo científico publicado en 2015

Antitumor activity in RAS-driven tumors by blocking AKT and MEK.

artículo científico publicado en 2014

Antitumor activity of nivolumab on hemodialysis after renal allograft rejection

scientific article published on 18 October 2016

Appraising iniparib, the PARP inhibitor that never was--what must we learn?

artículo científico publicado en 2013

Choroidal lymphoma with orbital and optic nerve extension: case and review of literature

artículo científico publicado en 2012

Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results From a Phase 1/2 Open-label Study.

artículo científico publicado en 2017

First-in-Human Pharmacokinetic and Pharmacodynamic Study of the Dual m-TORC 1/2 Inhibitor AZD2014.

artículo científico publicado en 2015

Immune Checkpoint Inhibitors: Game Changing Cancer Therapy With a Cardiac Cost. What Are the Mechanisms and Unresolved Questions in Cardiotoxicity?

scientific article published on 13 April 2018

Long-term benefits versus side-effects from bone-targeted therapies for cancer patients: minimizing risk while maximizing benefits.

artículo científico publicado en 2014

Neoadjuvant erlotinib and surgical resection of a stage iiia papillary adenocarcinoma of the lung with an L861Q activating EGFR mutation

artículo científico publicado en 2012

Novel drugs targeting the androgen receptor pathway in prostate cancer

artículo científico publicado en 2014

OX40 Agonist BMS-986178 Alone or in Combination With Nivolumab and/or Ipilimumab in Patients With Advanced Solid Tumors

artículo científico publicado en 2020

Octreotide in bronchobiliary fistula management.

artículo científico publicado en 2004

Pharmacological risk factors for amphotericin B nephrotoxicity in children.

artículo científico publicado en 2007

Recent advances in second-line treatment of castration-resistant prostate cancer.

scientific article published on September 2011

Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration

artículo científico publicado en 2015

Taxane acute pain syndrome (TAPS) in patients receiving chemotherapy for breast or prostate cancer: a prospective multi-center study.

artículo científico publicado en 2018

Taxane acute pain syndrome (TAPS) in patients receiving taxane-based chemotherapy for breast cancer-a systematic review.

artículo científico publicado en 2016

Treatment of taxane acute pain syndrome (TAPS) in cancer patients receiving taxane-based chemotherapy-a systematic review.

artículo científico

Unscheduled return visits to the pediatric emergency department-one-year experience

artículo científico publicado en 2006

Using a knowledge translation framework to implement asthma clinical practice guidelines in primary care ⬇️

artículo científico publicado el 14 de agosto de 2012

Validation and utilisation of high-coverage next-generation sequencing to deliver the pharmacological audit trail

artículo científico publicado en 2014

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda